Aurinia Pharmaceuticals Inc. (AUPH)
Latest AUPH Insider Trades
- Stephen P. Robertson - OfficerOpen-market sale$356K
Kevin Tang - OfficerOpen-market purchase$35K
About Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
- EDMONTON, A0
- 128
- 2009
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 5 | 814,606 | $12.46M |
| Open-market sale | 1 | 20,975 | $356K |
| Grant or award | 4 | 95,724 |
AUPH Insider Transactions (Form 4)
1034 Form 4 filings on record, the earliest from Nov 12, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Karen L. Smith - Director | Grant or award | Common Shares | 12,135 |
Recent AUPH Form 8-K Filings
5Recent AUPH Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Stephen P. Robertson | Officer | 47,000 | $719K | View on EDGAR | |
| - | - |
AUPH Insider Trading - FAQ
What is the latest insider trade for AUPH?
Aurinia Pharmaceuticals Inc. (AUPH) had 6 insider filings in the last 90 days, with the most recent on 2026-08-26. The full record for AUPH runs to 34 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AUPH stock?
5 insider purchases of AUPH were filed in the last 90 days, totaling $12.46M.
How many insiders are selling AUPH stock?
1 insider sale of AUPH was filed in the last 90 days, totaling $356K.
Where can I see AUPH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks AUPH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AUPH insider buys?
Create a free InsiderAlpha account and press Watch on this page to add AUPH to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Stephen P. Robertson view on EDGAR
- - Craig A. Johnson view on EDGAR
- - Kathleen Goetz view on EDGAR
- - Tina Susan Nova view on EDGAR
- - Jeffrey Allen Bailey view on EDGAR
- - Kevin Tang view on EDGAR
- - Stephen P. Robertson view on EDGAR
- - Michael S. Hearne view on EDGAR
- - Ryan Cole view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where AUPH's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track AUPH insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
